Latest News by Industry
Finch Therapeutics Group, Inc. [FNCH] has reported fiscal Q1 loss of $63.90 million.
On a per-share basis, the DE based company said its diluted earnings are $1.33.
The Biological Products, Except Diagnostic Substances firm posted revenue of $107 million in this period.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.